7/17/2024  9:43:38 PM Chg. +0.080 Volume Bid7/17/2024 Ask7/17/2024 Market Capitalization Dividend Y. P/E Ratio
36.300EUR +0.22% 810
Turnover: 29,373.450
36.250Bid Size: 275 36.490Ask Size: 275 10.53 bill.EUR 3.32% 21.11

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Helen Giza
Management board
Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola
Supervisory board
Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49 (0) 6172 609-2525
IR Fax: +49 (0) 6172 609-2301
IR e-mail: ir@fmc-ag.com

Company calendar

CW 31 | 7/30/2024 Interim Report 2nd Quarter/6 Months
CW 45 | 11/5/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Institutional investors
 
61.00%
Else-Kröner-Fresenius-Stiftung
 
27.00%
Retail holdings
 
8.00%
Not identified
 
4.00%